Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Biological Psychiatry|July 6, 2010
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonistGraham Searle, John D Beaver, Robert A Comley, et al.
The American Journal of Psychiatry|December 7, 2005
Altered prefrontal dopaminergic function in chronic recreational ketamine usersRajesh Narendran, W Gordon Frankle, Richard Keefe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 2011
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansPaul Shotbolt, Andri C Tziortzi, Graham E Searle, et al.
Molecular Imaging and Biology|August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PETSantiago Bullich, Mark Slifstein, Jan Passchier, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the BrainNabeel B Nabulsi, Joël Mercier, Daniel Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Plos One|September 21, 2011
Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkersJoshua H Balsters, Redmond G O'Connell, Mary P Martin, et al.
The International Journal of Neuropsychopharmacology|August 31, 2012
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunctionPradeep J Nathan, Jeannette Watson, Jesper Lund, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Biological Psychiatry|July 6, 2010
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonistGraham Searle, John D Beaver, Robert A Comley, et al.
The American Journal of Psychiatry|December 7, 2005
Altered prefrontal dopaminergic function in chronic recreational ketamine usersRajesh Narendran, W Gordon Frankle, Richard Keefe, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 1, 2011
Within-subject comparison of [(11)C]-(+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humansPaul Shotbolt, Andri C Tziortzi, Graham E Searle, et al.
Molecular Imaging and Biology|August 24, 2010
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PETSantiago Bullich, Mark Slifstein, Jan Passchier, et al.
Bioorganic & Medicinal Chemistry Letters|July 29, 2009
Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studiesIdriss Bennacef, Cristian A Salinas, Thomas A Bonasera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2016
Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the BrainNabeel B Nabulsi, Joël Mercier, Daniel Holden, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 21, 2013
Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomographyRobert A Comley, Cristian A Salinas, Mark Slifstein, et al.
Plos One|September 21, 2011
Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkersJoshua H Balsters, Redmond G O'Connell, Mary P Martin, et al.
The International Journal of Neuropsychopharmacology|August 31, 2012
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunctionPradeep J Nathan, Jeannette Watson, Jesper Lund, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|May 24, 2007
Consensus nomenclature for in vivo imaging of reversibly binding radioligandsRobert B Innis, Vincent J Cunningham, Jacques Delforge, et al.
Pageof 11